Announced Tue, 12 Aug · 20:32 IST

Biofil Chemicals & Pharmaceuticals Limited has informed the Exchange about Appointment of Secretarial Auditor

Management Changes View source PDF

BIOFILCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve

Awaiting price reaction for this filing.

AI summary

Biofil Chemicals & Pharmaceuticals has appointed Joshi Sahay and Company, Practicing Company Secretaries, as its new Secretarial Auditor for a 5-year term covering FY 2025-26 to FY 2029-30. The appointment was approved by the Board on August 12, 2025, based on the Audit Committee's recommendation, and is subject to shareholder approval at the upcoming 40th Annual General Meeting. The newly appointed firm, established in 2025, is peer-reviewed by the Institute of Company Secretaries of India, with the signing partner Mr. L.N. Joshi bringing over 25 years of experience in corporate laws, SEBI regulations, and insolvency matters. This appointment is made to comply with the Companies Act, 2013 and Regulation 24(A) of the SEBI LODR Regulations.

Likely market impact

This is a routine regulatory compliance appointment and does not materially affect the company's operations or financials. Shareholders will get to vote on confirming this appointment at the next AGM, but the decision is largely procedural.